Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-15

Clinical Trial Update: Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients [Phase 4]

View source ↗

Summary

Phase 4 study comparing insulin glargine to sitagliptin in insulin-naive adults with type 2 diabetes has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)
  • Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2012-08-15